IO Biotech, Inc.
IOBT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$95,491 | -$86,083 | -$71,458 | -$67,879 |
| Dep. & Amort. | $849 | $756 | $540 | $2 |
| Deferred Tax | $0 | $0 | $87 | -$2 |
| Stock-Based Comp. | $6,526 | $8,059 | $7,040 | $1,791 |
| Change in WC | $2,180 | $5,862 | $4,192 | -$776 |
| Other Non-Cash | $3,589 | -$331 | -$130 | $26,216 |
| Operating Cash Flow | -$82,347 | -$71,737 | -$59,729 | -$40,646 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$44 | -$323 | -$690 | -$153 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$44 | -$323 | -$690 | -$153 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $75,058 | $0 | $115,115 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$3,198 | $0 | $137,836 |
| Financing Cash Flow | $0 | $71,860 | $0 | $252,951 |
| Forex Effect | -$771 | $803 | -$8,522 | -$3,758 |
| Net Chg. in Cash | -$83,162 | $603 | -$68,941 | $208,394 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $143,461 | $142,858 | $211,799 | $3,405 |
| End Cash | $60,299 | $143,461 | $142,858 | $211,799 |
| Free Cash Flow | -$82,391 | -$72,060 | -$60,419 | -$40,799 |